Balyasny Asset Management »

Neuropace shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $307k 23k 13.15
2025-06-30 $0 0 0.00
2025-03-31 $274k 22k 12.29
2024-03-31 $356k 27k 13.20
2023-12-31 $280k 27k 10.31

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Neuropace

Soleus Capital Management
Polar Capital Holdings
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group

View all funds holding Neuropace